Our patient cohort data demonstrate a decreasing trend in SIRT3 protein levels and deacetylase activity among patients with Hoehn-Yahr (H–Y) stages 2–3.
← all excerpts
Mitochondrial acetyl-CoA reprogramming by the SIRT3-ACSS2-OPA1 axis confers resistance to ferroptosis in Parkinson's disease.
1
—
—